{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:21:21Z","timestamp":1793683281729,"version":"4.5.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-79225-1","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T19:22:42Z","timestamp":1735327362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Luliconazole-loaded nanostructured lipid carrier: formulation, characterization, and in vitro antifungal evaluation against a panel of resistant fungal strains"],"prefix":"10.1038","volume":"14","author":[{"given":"Mohsen","family":"Nosratabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Mobin","family":"Rahimnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robab Ebrahimi","family":"Barogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Abastabar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Haghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Akhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Hajheydari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Ebrahimnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,28]]},"reference":[{"key":"79225_CR1","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fmicb.2019.00214","volume":"10","author":"F Almeida","year":"2019","unstructured":"Almeida, F., Rodrigues, M. L. & Coelho, C. The still underestimated problem of fungal diseases worldwide. Front. Microbiol. 10, 214 (2019).","journal-title":"Front. Microbiol."},{"key":"79225_CR2","first-page":"100137","volume":"3","author":"GKK Reddy","year":"2022","unstructured":"Reddy, G. K. K., Padmavathi, A. R. & Nancharaiah, Y. Fungal infections: Pathogenesis, antifungals and alternate treatment approaches. Curr. Res. Microb. Sci. 3, 100137 (2022).","journal-title":"Curr. Res. Microb. Sci."},{"key":"79225_CR3","doi-asserted-by":"publisher","first-page":"a019273","DOI":"10.1101\/cshperspect.a019273","volume":"5","author":"JR K\u00f6hler","year":"2015","unstructured":"K\u00f6hler, J. R., Casadevall, A. & Perfect, J. The spectrum of fungi that infects humans. Cold Spring Harbor Perspect. Med. 5, a019273 (2015).","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"79225_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3390\/jof9060669","volume":"9","author":"P Chanyachailert","year":"2023","unstructured":"Chanyachailert, P., Leeyaphan, C. & Bunyaratavej, S. Cutaneous fungal infections caused by dermatophytes and non-dermatophytes: an updated comprehensive review of epidemiology, clinical presentations, and diagnostic testing. J. Fungi.  9, 669 (2023).","journal-title":"J. Fungi"},{"key":"79225_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/jof8010039","volume":"8","author":"SR Jartarkar","year":"2021","unstructured":"Jartarkar, S. R. et al. Pathogenesis, immunology and management of dermatophytosis. J. Fungi.  8, 39 (2021).","journal-title":"J. Fungi"},{"key":"79225_CR6","doi-asserted-by":"publisher","first-page":"12669","DOI":"10.1038\/s41598-024-63425-w","volume":"14","author":"HR Mahmood","year":"2024","unstructured":"Mahmood, H. R., Shams-Ghahfarokhi, M., Salehi, Z. & Razzaghi-Abyaneh, M. Epidemiological trends, antifungal drug susceptibility and SQLE point mutations in etiologic species of human dermatophytosis in Al-Diwaneyah, Iraq. Sci. Rep. 14, 12669 (2024).","journal-title":"Sci. Rep."},{"key":"79225_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11046-010-9373-7","volume":"171","author":"J Jayatilake","year":"2011","unstructured":"Jayatilake, J. A review of the ultrastructural features of superficial candidiasis. Mycopathologia  171, 235\u2013250 (2011).","journal-title":"Mycopathologia"},{"key":"79225_CR8","first-page":"352","volume":"3","author":"G Teklebirhan","year":"2015","unstructured":"Teklebirhan, G. & Bitew, A. Profile of dermatophyte and non dermatophyte fungi in patients suspected of dermatophytosis. Am. J. Life Sci. 3, 352 (2015).","journal-title":"Am. J. Life Sci."},{"key":"79225_CR9","unstructured":"Gesew, G. T. Prevalence of dermatophytes and non-dermatophyte fungal Infection among patients visiting dermatology clinic, at Tikur Anbessa hospital (Addis Ababa, Ethiopia, Addis Ababa University, 2014)."},{"key":"79225_CR10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/jdv.19644","volume":"38","author":"AK Gupta","year":"2024","unstructured":"Gupta, A. K. et al. A comprehensive review of nondermatophyte mould onychomycosis: epidemiology, diagnosis and management. J. Eur. Acad. Dermatol. Venereol. 38, 480\u2013495 (2024).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"79225_CR11","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3390\/antibiotics9120877","volume":"9","author":"A Arastehfar","year":"2020","unstructured":"Arastehfar, A. et al. Drug-resistant fungi: an emerging challenge threatening our limited antifungal armamentarium. Antibiotics  9, 877 (2020).","journal-title":"Antibiotics"},{"key":"79225_CR12","doi-asserted-by":"crossref","unstructured":"Khanna, D. & Bharti, S. Luliconazole for the treatment of fungal infections: an evidence-based review. Core Evid.  113\u2013124 (2014).","DOI":"10.2147\/CE.S49629"},{"key":"79225_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10156-006-0440-4","volume":"12","author":"H Koga","year":"2006","unstructured":"Koga, H. et al. In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses. J. Infect. Chemother. 12, 163\u2013165 (2006).","journal-title":"J. Infect. Chemother."},{"key":"79225_CR14","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1128\/AAC.05255-11","volume":"56","author":"H Koga","year":"2012","unstructured":"Koga, H., Nanjoh, Y., Kaneda, H., Yamaguchi, H. & Tsuboi, R. Short-term therapy with luliconazole, a novel topical antifungal imidazole, in guinea pig models of tinea corporis and tinea pedis. Antimicrob. Agents Chemother. 56, 3138\u20133143 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"79225_CR15","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3390\/pharmaceutics12070684","volume":"12","author":"C Gorzelanny","year":"2020","unstructured":"Gorzelanny, C., Mess, C., Schneider, S. W., Huck, V. & Brandner, J. M. Skin barriers in dermal drug delivery: which barriers have to be overcome and how can we measure them? Pharmaceutics  12, 684 (2020).","journal-title":"Pharmaceutics"},{"key":"79225_CR16","doi-asserted-by":"publisher","first-page":"e13959","DOI":"10.1111\/dth.13959","volume":"33","author":"S Baghel","year":"2020","unstructured":"Baghel, S. et al. Luliconazole-loaded nanostructured lipid carriers for topical treatment of superficial Tinea infections. Dermatol. Ther. 33, e13959 (2020).","journal-title":"Dermatol. Ther."},{"key":"79225_CR17","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.3390\/molecules21121719","volume":"21","author":"BC Palmer","year":"2016","unstructured":"Palmer, B. C. & DeLouise, L. A. Nanoparticle-enabled transdermal drug delivery systems for enhanced dose control and tissue targeting. Molecules  21, 1719 (2016).","journal-title":"Molecules"},{"key":"79225_CR18","doi-asserted-by":"publisher","first-page":"646554","DOI":"10.3389\/fbioe.2021.646554","volume":"9","author":"YQ Yu","year":"2021","unstructured":"Yu, Y. Q., Yang, X., Wu, X. F. & Fan, Y. B. Enhancing permeation of drug molecules across the skin via delivery in nanocarriers: novel strategies for effective transdermal applications. Front. Bioeng. Biotechnol. 9, 646554 (2021).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"79225_CR19","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/pharmaceutics14040883","volume":"14","author":"SZ Alshawwa","year":"2022","unstructured":"Alshawwa, S. Z., Kassem, A. A., Farid, R. M., Mostafa, S. K. & Labib, G. S. Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence. Pharmaceutics  14, 883 (2022).","journal-title":"Pharmaceutics"},{"key":"79225_CR20","doi-asserted-by":"crossref","unstructured":"Ghasemiyeh, P. & Mohammadi-Samani, S. Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: advantages and disadvantages. Drug. Des. Devel. Ther., 3271\u20133289 (2020).","DOI":"10.2147\/DDDT.S264648"},{"key":"79225_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s40011-012-0080-7","volume":"82","author":"S Gupta","year":"2012","unstructured":"Gupta, S. & Kumar, P. Drug delivery using nanocarriers: Indian perspective. Proc. Natl. Acad. Sci. India Sect. B: Biol. Sci. 82, 167\u2013206 (2012).","journal-title":"Proc. Natl. Acad. Sci. India Sect. B: Biol. Sci."},{"key":"79225_CR22","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.3390\/molecules26123587","volume":"26","author":"CMB Pinilla","year":"2021","unstructured":"Pinilla, C. M. B., Lopes, N. A. & Brandelli, A. Lipid-based nanostructures for the delivery of natural antimicrobials. Molecules  26, 3587 (2021).","journal-title":"Molecules"},{"key":"79225_CR23","doi-asserted-by":"publisher","first-page":"102397","DOI":"10.1016\/j.jddst.2021.102397","volume":"62","author":"S Nene","year":"2021","unstructured":"Nene, S. et al. Lipid based nanocarriers: a novel paradigm for topical antifungal therapy. J. Drug Deliv. Sci. Technol. 62, 102397 (2021).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"79225_CR24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/pharmaceutics12030288","volume":"12","author":"M Haider","year":"2020","unstructured":"Haider, M., Abdin, S. M., Kamal, L. & Orive, G. Nanostructured lipid carriers for delivery of chemotherapeutics: a review. Pharmaceutics  12, 288 (2020).","journal-title":"Pharmaceutics"},{"key":"79225_CR25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3390\/pharmaceutics15020657","volume":"15","author":"EA Madawi","year":"2023","unstructured":"Madawi, E. A. et al. Polymeric nanoparticles as tunable nanocarriers for targeted delivery of drugs to skin tissues for treatment of topical skin diseases. Pharmaceutics  15, 657 (2023).","journal-title":"Pharmaceutics"},{"key":"79225_CR26","first-page":"113","volume":"4","author":"MR Talei","year":"2023","unstructured":"Talei, M. R. Metal nanoparticles as Novel Drug Delivery systems: a review of current challenges and opportunities. Iraqi J. Nat. Sci. Nanatechnol. 4, 113\u2013140 (2023).","journal-title":"Iraqi J. Nat. Sci. Nanatechnol."},{"key":"79225_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"JK Patra","year":"2018","unstructured":"Patra, J. K. et al. Nano based drug delivery systems: recent developments and future prospects. J. Nanobiotechnol. 16, 1\u201333 (2018).","journal-title":"J. Nanobiotechnol."},{"key":"79225_CR28","doi-asserted-by":"crossref","unstructured":"Thenge, R. R., Patel, A. & Mehetre, G. In photophysics and nanophysics in therapeutics443\u2013454 (Elsevier, 2022).","DOI":"10.1016\/B978-0-323-89839-3.00014-2"},{"key":"79225_CR29","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.jsps.2021.07.015","volume":"29","author":"M Elmowafy","year":"2021","unstructured":"Elmowafy, M. & Al-Sanea, M. M. Nanostructured lipid carriers (NLCs) as drug delivery platform: advances in formulation and delivery strategies. Saudi Pharm. J. 29, 999\u20131012 (2021).","journal-title":"Saudi Pharm. J."},{"key":"79225_CR30","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","volume":"103","author":"A Khosa","year":"2018","unstructured":"Khosa, A., Reddi, S. & Saha, R. N. Nanostructured lipid carriers for site-specific drug delivery. Biomed. Pharmacother. 103, 598\u2013613 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"79225_CR31","doi-asserted-by":"publisher","first-page":"446","DOI":"10.34172\/apb.2023.056","volume":"13","author":"S Khan","year":"2023","unstructured":"Khan, S., Sharma, A. & Jain, V. An overview of nanostructured lipid carriers and its application in drug delivery through different routes. Adv. Pharm. Bull. 13, 446 (2023).","journal-title":"Adv. Pharm. Bull."},{"key":"79225_CR32","first-page":"247","volume":"71","author":"S Babaei","year":"2016","unstructured":"Babaei, S. et al. Enhanced skin penetration of lidocaine through encapsulation into nanoethosomes and nanostructured lipid carriers: a comparative study. Die Pharmazie-An Int. J. Pharm. Sci. 71, 247\u2013251 (2016).","journal-title":"Die Pharmazie-An Int. J. Pharm. Sci."},{"key":"79225_CR33","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s11051-010-9998-y","volume":"13","author":"D Liu","year":"2011","unstructured":"Liu, D. et al. Diclofenac sodium-loaded solid lipid nanoparticles prepared by emulsion\/solvent evaporation method. J. Nanopart. Res. 13, 2375\u20132386 (2011).","journal-title":"J. Nanopart. Res."},{"key":"79225_CR34","first-page":"78","volume":"32","author":"AS Shirazi","year":"2021","unstructured":"Shirazi, A. S., Varshochian, R., Rezaei, M., Ardakani, Y. H. & Dinarvand, R. SN38 loaded nanostructured lipid carriers (NLCs); preparation and in vitro evaluations against glioblastoma. J. Mater. Sci. Mater. Med. 32, 78 (2021).","journal-title":"J. Mater. Science: Mater. Med."},{"key":"79225_CR35","first-page":"161","volume":"14","author":"M Saeedi","year":"2024","unstructured":"Saeedi, M. et al. Green formulation of spironolactone loaded chitosan-coated nano lipid carrier for treatment of acne vulgaris: a randomized double-blind clinical trial. Adv. Pharm. Bull. 14, 161 (2024).","journal-title":"Adv. Pharm. Bull."},{"key":"79225_CR36","unstructured":"TORRISI, C., Design & Preparation and characterization of nanoparticle systems as caerriers of biologically active substances."},{"key":"79225_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1208\/s12249-024-02858-y","volume":"25","author":"SM Rahimnia","year":"2024","unstructured":"Rahimnia, S. M. et al. Development, optimization, and in vitro evaluation of Silybin-loaded PLGA nanoparticles and decoration with 5TR1 aptamer for targeted delivery to Colorectal Cancer cells. AAPS PharmSciTech. 25, 141 (2024).","journal-title":"AAPS PharmSciTech"},{"key":"79225_CR38","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.3390\/molecules27103347","volume":"27","author":"M Farooq","year":"2022","unstructured":"Farooq, M. et al. Fabrication and evaluation of voriconazole loaded transethosomal gel for enhanced antifungal and antileishmanial activity. Molecules. 27, 3347 (2022).","journal-title":"Molecules"},{"key":"79225_CR39","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s12247-023-09733-6","volume":"18","author":"M Saeedi","year":"2023","unstructured":"Saeedi, M. et al. Passive targeted drug delivery of venlafaxine hcl to the brain by modified chitosan nanoparticles: characterization, cellular safety assessment, and in vivo evaluation. J. Pharm. Innov. 18, 1441\u20131453 (2023).","journal-title":"J. Pharm. Innov."},{"key":"79225_CR40","doi-asserted-by":"crossref","unstructured":"Qureshi, M. I. et al. Tioconazole-Loaded Transethosomal Gel Using Box\u2013Behnken Design for Topical Applications: In Vitro, In Vivo, and Molecular Docking Approaches. Gels 9, 767 (2023).","DOI":"10.3390\/gels9090767"},{"key":"79225_CR41","unstructured":"KUMAR, V. OPTIMIZATION AND EVALUATION OF TOPICAL GEL CONTAINING SOLID LIPID NANOPARTICLES LOADED WITH LULICONAZOLE (Uttar Pradesh Technical University, 2020)."},{"key":"79225_CR42","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1080\/09205063.2023.2201817","volume":"34","author":"M Saeedi","year":"2023","unstructured":"Saeedi, M. et al. Eco-friendly preparation, characterization, evaluation of anti-melanogenesis\/antioxidant effect and in vitro\/in vivo safety profile of kojic acid loaded niosome as skin lightener preparation. J. Biomater. Sci. Polym. Ed. 34, 1952\u20131980 (2023).","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"79225_CR43","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/21691401.2021.1907393","volume":"49","author":"F Sharifi","year":"2021","unstructured":"Sharifi, F., Jahangiri, M. & Ebrahimnejad, P. Synthesis of novel polymeric nanoparticles (methoxy-polyethylene glycol-chitosan\/hyaluronic acid) containing 7-ethyl-10-hydroxycamptothecin for colon cancer therapy: in vitro, ex vivo and in vivo investigation. Artif. Cells Nanomed. Biotechnol. 49, 367\u2013380 (2021).","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"79225_CR44","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s12247-023-09710-z","volume":"18","author":"J Akbari","year":"2023","unstructured":"Akbari, J. et al. An eco-friendly and hopeful promise platform for delivering hydrophilic wound healing agents in topical administration for wound disorder: diltiazem-loaded niosomes. J. Pharm. Innov. 18, 1111\u20131127 (2023).","journal-title":"J. Pharm. Innov."},{"key":"79225_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.34172\/PS.2023.23","volume":"30","author":"SM Rahimnia","year":"2023","unstructured":"Rahimnia, S. M. et al. Green preparation, characterization, wound healing assessment, and histopathological evaluation of vitamin A encapsulated in niosome and solid lipid nanoparticle. Pharm. Sci. 30, 70\u201384 (2023).","journal-title":"Pharm. Sci."},{"key":"79225_CR46","doi-asserted-by":"publisher","first-page":"101579","DOI":"10.1016\/j.jddst.2020.101579","volume":"56","author":"AS Taleghani","year":"2020","unstructured":"Taleghani, A. S., Ebrahimnejad, P., Heydarinasab, A. & Akbarzadeh, A. Adsorption and controlled release of iron-chelating drug from the amino-terminated PAMAM\/ordered mesoporous silica hybrid materials. J. Drug Deliv. Sci. Technol. 56, 101579 (2020).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"79225_CR47","doi-asserted-by":"publisher","first-page":"102543","DOI":"10.1016\/j.jddst.2021.102543","volume":"63","author":"B Hasan-Nasab","year":"2021","unstructured":"Hasan-Nasab, B. et al. A promising targeting system to enrich irinotecan antitumor efficacy: folic acid targeted nanoparticles. J. Drug Deliv. Sci. Technol. 63, 102543 (2021).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"79225_CR48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11046-024-00855-0","volume":"189","author":"I Haghani","year":"2024","unstructured":"Haghani, I. et al. High prevalence of Terbinafine Resistance among Trichophyton mentagrophytes\/T. Interdigitale Species Complex, a cross-sectional study from 2021 to 2022 in Northern Parts of Iran. Mycopathologia. 189, 52 (2024).","journal-title":"Mycopathologia"},{"key":"79225_CR49","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jhin.2023.12.011","volume":"145","author":"M Ghazanfari","year":"2024","unstructured":"Ghazanfari, M. et al. Electronic equipment and appliances in special wards of hospitals as a source of azole-resistant aspergillus fumigatus: a multi-centre study from Iran. J. Hosp. Infect. 145, 65\u201376 (2024).","journal-title":"J. Hosp. Infect."},{"key":"79225_CR50","doi-asserted-by":"publisher","first-page":"00009","DOI":"10.1128\/aac","volume":"62","author":"M Abastabar","year":"2018","unstructured":"Abastabar, M. et al. Potent activities of luliconazole, lanoconazole, and eight comparators against molecularly characterized Fusarium species. Antimicrob. Agents Chemother. 62, 00009\u201300018. https:\/\/doi.org\/10.1128\/aac (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"79225_CR51","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11046-020-00460-x","volume":"185","author":"MJ Najafzadeh","year":"2020","unstructured":"Najafzadeh, M. J. et al. Phylogenetic analysis of clinically relevant Fusarium species in Iran. Mycopathologia. 185, 515\u2013525 (2020).","journal-title":"Mycopathologia"},{"key":"79225_CR52","doi-asserted-by":"publisher","first-page":"1152552","DOI":"10.3389\/fcimb.2023.1152552","volume":"13","author":"M Sharifi","year":"2023","unstructured":"Sharifi, M. et al. A 3-year study of Candida infections among patients with malignancy: etiologic agents and antifungal susceptibility profile. Front. Cell. Infect. Microbiol. 13, 1152552 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"79225_CR53","unstructured":"TAGHIZADEH, A. M. et al. Identification and antifungal susceptibility testing of Candida species isolated from bronchoalveolar lavage samples. (2014)."},{"key":"79225_CR54","doi-asserted-by":"publisher","first-page":"6916","DOI":"10.1128\/AAC.01193-16","volume":"60","author":"M Abastabar","year":"2016","unstructured":"Abastabar, M. et al. Potent activities of novel imidazoles lanoconazole and luliconazole against a collection of azole-resistant and-susceptible aspergillus fumigatus strains. Antimicrob. Agents Chemother. 60, 6916\u20136919 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"79225_CR55","unstructured":"Wayne, P. CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, 3rd ed.; CLSI standard M38; Clinical and Laboratory Standards Institute. (2017)."},{"key":"79225_CR56","unstructured":"Procop Gd, P. et al. Clinical and Laboratory Standards Institute: M60-ED 1: Performance Standards for Antifungal Susceptibility Testing of Yeasts (Wayne, NJ, USA., 2017)."},{"key":"79225_CR57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/cosmetics8030069","volume":"8","author":"M Luki\u0107","year":"2021","unstructured":"Luki\u0107, M., Panteli\u0107, I. & Savi\u0107, S. D. Towards optimal Ph of the skin and topical formulations: from the current state of the art to tailored products. Cosmetics. 8, 69 (2021).","journal-title":"Cosmetics"},{"key":"79225_CR58","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.progpolymsci.2007.09.003","volume":"33","author":"JH Park","year":"2008","unstructured":"Park, J. H. et al. Polymeric nanomedicine for cancer therapy. Prog. Polym. Sci. 33, 113\u2013137 (2008).","journal-title":"Prog. Polym. Sci."},{"key":"79225_CR59","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1166\/jbn.2007.049","volume":"3","author":"E Souto","year":"2007","unstructured":"Souto, E., Almeida, A. & M\u00fcller, R. Lipid nanoparticles (SLN\u00ae, NLC\u00ae) for cutaneous drug delivery: structure, protection and skin effects. J. Biomed. Nanotechnol.3, 317\u2013331 (2007).","journal-title":"J. Biomed. Nanotechnol."},{"key":"79225_CR60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.colsurfb.2011.12.004","volume":"92","author":"CK Song","year":"2012","unstructured":"Song, C. K. et al. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro\/in vivo evaluation. Colloids Surf., B. 92, 299\u2013304 (2012).","journal-title":"Colloids Surf., B"},{"key":"79225_CR61","doi-asserted-by":"crossref","unstructured":"Kumar, M., Shanthi, N., Mahato, A. K., Soni, S. & Rajnikanth, P. Preparation of luliconazole nanocrystals loaded hydrogel for improvement of dissolution and antifungal activity. Heliyon 5 (2019).","DOI":"10.1016\/j.heliyon.2019.e01688"},{"key":"79225_CR62","doi-asserted-by":"publisher","first-page":"095010","DOI":"10.1088\/2053-1591\/2\/9\/095010","volume":"2","author":"J Ibarra","year":"2015","unstructured":"Ibarra, J. et al. Synthesis and characterization of magnetite\/PLGA\/chitosan nanoparticles. Mater. Res. Express. 2, 095010 (2015).","journal-title":"Mater. Res. Express"},{"key":"79225_CR63","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1007\/s10924-017-1175-2","volume":"26","author":"WS Ng","year":"2018","unstructured":"Ng, W. S., Lee, C. S., Cheng, S. F., Chuah, C. H. & Wong, S. F. Biocompatible polyurethane scaffolds prepared from glycerol monostearate-derived polyester polyol. J. Polym. Environ. 26, 2881\u20132900 (2018).","journal-title":"J. Polym. Environ."},{"key":"79225_CR64","doi-asserted-by":"publisher","first-page":"101302","DOI":"10.1016\/j.jddst.2019.101302","volume":"55","author":"GR Kapileshwari","year":"2020","unstructured":"Kapileshwari, G. R. et al. Novel drug delivery system of luliconazole-formulation and characterisation. J. Drug Deliv. Sci. Technol. 55, 101302 (2020).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"79225_CR65","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ejpb.2022.10.018","volume":"181","author":"H Ebrahimi","year":"2022","unstructured":"Ebrahimi, H. et al. Design and optimization of metformin-loaded solid lipid nanoparticles for neuroprotective effects in a rat model of diffuse traumatic brain injury: a biochemical, behavioral, and histological study. Eur. J. Pharm. Biopharm. 181, 122\u2013135 (2022).","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"79225_CR66","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3797\/scipharm.1202-12","volume":"80","author":"D Patel","year":"2012","unstructured":"Patel, D. et al. Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: preparation, characterization, and in vivo evaluation. Sci. Pharm. 80, 749\u2013764 (2012).","journal-title":"Sci. Pharm."},{"key":"79225_CR67","first-page":"233","volume":"44","author":"N Harish","year":"2007","unstructured":"Harish, N., Kiran, A., Rathnanand, M., Shirwaikar, A. & Shenoy, K. Sustained-release matrix tablets of terbutaline sulphate: Formulation and in vitro evaluation. Indian Drugs. 44, 233\u2013235 (2007).","journal-title":"Indian Drugs"},{"key":"79225_CR68","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0168-3659(87)90034-4","volume":"5","author":"PL Ritger","year":"1987","unstructured":"Ritger, P. L. & Peppas, N. A. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Controlled Release. 5, 23\u201336 (1987).","journal-title":"J. Controlled Release"},{"key":"79225_CR69","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/mmy\/myw016","volume":"54","author":"N Baghi","year":"2016","unstructured":"Baghi, N. et al. In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates. Med. Mycol. 54, 757\u2013763 (2016).","journal-title":"Med. Mycol."},{"key":"79225_CR70","doi-asserted-by":"crossref","unstructured":"Shokoohi, G. et al. In vitro antifungal activity of luliconazole, efinaconazole, and nine comparators against Aspergillus and Candida strains isolated from otomycosis. Jundishapur J. Microbiol. 14 (2021).","DOI":"10.5812\/jjm.115902"},{"key":"79225_CR71","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/myc.13550","volume":"66","author":"M Nosratabadi","year":"2023","unstructured":"Nosratabadi, M. et al. In vitro antifungal susceptibility profile of Iranian Fusarium isolates: emphasising on the potent inhibitory effect of efinaconazole compared to other drugs. Mycoses. 66, 258\u2013275 (2023).","journal-title":"Mycoses"},{"key":"79225_CR72","doi-asserted-by":"publisher","first-page":"105028","DOI":"10.1016\/j.chemphyslip.2020.105028","volume":"234","author":"A Mahmood","year":"2021","unstructured":"Mahmood, A., Rapalli, V. K., Waghule, T., Gorantla, S. & Singhvi, G. Luliconazole loaded lyotropic liquid crystalline nanoparticles for topical delivery: QbD driven optimization, in-vitro characterization and dermatokinetic assessment. Chem. Phys. Lipids. 234, 105028 (2021).","journal-title":"Chem. Phys. Lipids"},{"key":"79225_CR73","first-page":"52","volume":"13","author":"J YALLAVULA","year":"2023","unstructured":"YALLAVULA, J., MANDAVA, K. & MADHAV, V. Design and evaluation of topical gel containing solid-lipid nanoparticles loaded with luliconazole. Int. J. Pharm. Res. Technol. (IJPRT). 13, 52\u201364 (2023).","journal-title":"Int. J. Pharm. Res. Technol. (IJPRT)"},{"key":"79225_CR74","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1080\/09205063.2021.1892471","volume":"32","author":"AK Garg","year":"2021","unstructured":"Garg, A. K. et al. Solubility enhancement, formulation development and antifungal activity of luliconazole niosomal gel-based system. J. Biomater. Sci. Polym. Ed. 32, 1009\u20131023 (2021).","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"79225_CR75","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.3390\/pharmaceutics14102052","volume":"14","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. Development of a luliconazole nanoemulsion as a prospective ophthalmic delivery system for the treatment of fungal keratitis: in vitro and in vivo evaluation. Pharmaceutics. 14, 2052 (2022).","journal-title":"Pharmaceutics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79225-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T08:02:42Z","timestamp":1735372962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79225-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,28]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["79225"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-79225-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4342899\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,28]]},"assertion":[{"value":"29 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30708"}}